Correlation Between Body and Delta 9
Can any of the company-specific risk be diversified away by investing in both Body and Delta 9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Body and Delta 9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Body and Mind and Delta 9 Cannabis, you can compare the effects of market volatilities on Body and Delta 9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Body with a short position of Delta 9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Body and Delta 9.
Diversification Opportunities for Body and Delta 9
Pay attention - limited upside
The 3 months correlation between Body and Delta is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Body and Mind and Delta 9 Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Delta 9 Cannabis and Body is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Body and Mind are associated (or correlated) with Delta 9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Delta 9 Cannabis has no effect on the direction of Body i.e., Body and Delta 9 go up and down completely randomly.
Pair Corralation between Body and Delta 9
If you would invest 0.80 in Delta 9 Cannabis on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Delta 9 Cannabis or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Body and Mind vs. Delta 9 Cannabis
Performance |
| Timeline |
| Body and Mind |
| Delta 9 Cannabis |
Body and Delta 9 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Body and Delta 9
The main advantage of trading using opposite Body and Delta 9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Body position performs unexpectedly, Delta 9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delta 9 will offset losses from the drop in Delta 9's long position.| Body vs. Goodness Growth Holdings | Body vs. 4Front Ventures Corp | Body vs. Rubicon Organics | Body vs. CLS Holdings USA |
| Delta 9 vs. Benchmark Botanics | Delta 9 vs. Speakeasy Cannabis Club | Delta 9 vs. City View Green | Delta 9 vs. BC Craft Supply |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |